RT Journal Article
SR Electronic
T1 Mechanical ventilation affects respiratory microbiome of COVID-19 patients and its interactions with the host
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.23.20248425
DO 10.1101/2020.12.23.20248425
A1 Lloréns-Rico, Verónica
A1 Gregory, Ann C.
A1 Weyenbergh, Johan Van
A1 Jansen, Sander
A1 Buyten, Tina Van
A1 Qian, Junbin
A1 Braz, Marcos
A1 Menezes, Soraya Maria
A1 Mol, Pierre Van
A1 Vanderbeke, Lore
A1 Dooms, Christophe
A1 Gunst, Jan
A1 Hermans, Greet
A1 Meersseman, Philippe
A1 collaborators, CONTAGIOUS
A1 Wauters, Els
A1 Neyts, Johan
A1 Lambrechts, Diether
A1 Wauters, Joost
A1 Raes, Jeroen
YR 2021
UL http://medrxiv.org/content/early/2021/02/07/2020.12.23.20248425.abstract
AB Understanding the pathology of COVID-19 is a global research priority. Early evidence suggests that the microbiome may be playing a role in disease progression, yet current studies report contradictory results. Here, we examine potential confounders in COVID-19 microbiome studies by analyzing the upper (n=58) and lower (n=35) respiratory tract microbiome in well-phenotyped COVID-19 patients and controls combining microbiome sequencing, viral load determination, and immunoprofiling. We found that time in the intensive care unit and the type of oxygen support explained the most variation within the upper respiratory tract microbiome, dwarfing (non-significant) effects from viral load, disease severity, and immune status. Specifically, mechanical ventilation was linked to altered community structure, lower species- and higher strain-level diversity, and significant shifts in oral taxa previously associated with COVID-19. Single-cell transcriptomic analysis of the lower respiratory tract of ventilated COVID-19 patients identified increased oral microbiota compared to controls. These oral microbiota were found physically associated with proinflammatory immune cells, which showed higher levels of inflammatory markers. Overall, our findings suggest confounders are driving contradictory results in current COVID-19 microbiome studies and careful attention needs to be paid to ICU stay and type of oxygen support, as bacteria favored in these conditions may contribute to the inflammatory phenotypes observed in severe COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04327570Clinical Protocols https://clinicaltrials.gov/ct2/show/NCT04327570 Funding StatementThis study has been supported by funding from the VIB Grand Challenges Program. VLR is supported by an FWO senior postdoctoral fellowship (12V9421N). ACG is supported by an EMBO postdoctoral fellowship (ALTF 349-2019). The Raes lab is supported by KU Leuven, the Rega institute and VIB.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was reviewed and approved by the Ethics Commission at UZ Leuven hospitalAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw amplicon sequencing data generated in this study will be submitted to the EGA repository with controlled access.